cantestogo

OBPM LOOKS BULLISH DRIVEN BY NEWS

做多
OTC:OBMP   None
OBPM looks bullish after this news: "Departments of Urology and Oncology Approve Protocol for OncBioMune's Phase 2/3 Trial of ProscaVax for Prostate Cancer in Mexico". From a technical point of view there is a double bottom, bullish divergence, small degree downtrend broken and increase in volume.

免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。